MetaCap

Delcath Systems Financial Ratios

NASDAQ: DCTHHealth CareMedical/Dental InstrumentsUSD

15.36+0.32 (+2.13%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Delcath Systems ratio analysis

Delcath Systems earned a net margin of 3.2% in FY 2025, up from -70.9% a year earlier. Gross margin was 86.2% compared with a median of 74.5% over the prior 6 years. Return on equity reached 2.4%, meaning Delcath Systems generated 0.02 dollars of profit for every dollar of shareholders' equity.

Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.

Summary generated from market data by MetaCap's automated system. Methodology

Delcath Systems financial ratios (annual)

Delcath Systems annual financial ratios
RatioFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
P/E ratio (at fiscal year end)142.14—————————
Price / sales4.189.7132.7011.7415.58—————
Price / book3.205.254.28—4.632.35————
Gross margin86.2%83.4%69.2%74.8%81.1%———74.2%72.4%
Operating margin0.8%-33.4%-1,849.0%-1,245.1%-690.0%———-669.1%-825.3%
Net margin3.2%-70.9%-2,308.9%-1,342.7%-721.5%———-1,661.8%-902.2%
Free cash flow margin24.6%-51.7%-1,516.2%-925.3%-639.9%———-586.4%-726.5%
Return on equity (ROE)2.4%-38.4%-302.2%—-214.6%-109.4%——-6,654.4%—
Return on assets (ROA)2.2%-34.5%-123.5%-204.4%-77.4%-69.7%-62.5%-280.9%-507.7%-51.0%
Debt / equity—0.000.64———————
Current ratio10.9212.012.261.105.233.220.790.330.970.95
Revenue growth129.1%1,701.7%-24.1%-23.5%————36.3%14.0%

Related